Cargando…
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), is a set of clinically chronic, relapsing gastrointestinal inflammatory disease and lacks of an absolute cure. Although the precise etiology is unknown, developments in high-throughput microbial genomic se...
Autores principales: | Li, Mengfan, Yang, Lijiao, Mu, Chenlu, Sun, Yue, Gu, Yu, Chen, Danfeng, Liu, Tianyu, Cao, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125655/ https://www.ncbi.nlm.nih.gov/pubmed/35664229 http://dx.doi.org/10.1016/j.csbj.2022.03.038 |
Ejemplares similares
-
Multi-omics in Crohn's disease: New insights from inside
por: Mu, Chenlu, et al.
Publicado: (2023) -
Fecal microbiota transplantation in cancer management: Current status and perspectives
por: Chen, Danfeng, et al.
Publicado: (2018) -
Revisiting the “starved gut” hypothesis in inflammatory bowel disease
por: Colgan, Sean P., et al.
Publicado: (2023) -
Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022) -
Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
por: Yang, Min, et al.
Publicado: (2021)